Stay updated with breaking news from Immunization Managers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Missteps and delays have hampered the U.S. effort to vaccinate people against monkeypox. Now state health officials and community members are trying to adapt to a controversial "dose sparing" plan.
The new U.S. monkeypox vaccine strategy will try to squeeze more vaccines out of a single dose
Nursing homes might again find themselves in a COVID vaccine efficacy debate this fall, yet wiser than in from the pandemic's early days.
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/tronc/6KZMDT657IX3D43M7REGAQ45FQ.jpg)
The federal government’s distribution of monkeypox vaccine has been blemished by missteps and confusion, according to interviews with state health officials and documents obtained by The New York Times.
State officials are blaming the federal government for shortcomings in the nation's monkeypox vaccine rollout. They complain the system is clunky and inefficient.